Skip to main content

Table 1 Demographic data for patients participated in the study

From: Topiramate-induced ocular side effects in Egyptian patients, idiosyncratic versus dose-dependent effect, a prospective study

Presumed predictor

Patients receiving TPM

Age (years)

26.2 ± 10.3

Sex

8 males (40 %); 12 females (60 %)

Disease

10 (50%) patients suffered epilepsy and the other 10 (50%) suffered migraine

Stable TPM dose

7 (35%) used 50 mg/day, 8 (40%) used 100 mg/day, and 5 (25%) used 200 mg/day

  1. TPM topiramate